- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02153268
Filling Bone Defects/Voids With Autologous BonoFill For Maxillofacial Bone Regeneration
Phase I/II Open Label FIH Single Center Clinical Study Aimed to Evaluate the Safety and the Efficacy of BonoFill in Reconstructing the Bone.
Phase I/II open label first in human single center clinical study, is to evaluate the safety and the efficacy of BonoFill as bone filler containing the patient own (autologous) adipose tissue derived cells (HATDCs) in reconstructing the Bone Void in the maxillofacial area approximately 6 month follow up after implantation in the following two clinical indications:
- Bone augmentation (e.g. sinus augmentation)
- Bone grafting after removal of cysts from jaws
Study Overview
Status
Conditions
Detailed Description
Primary endpoint: The implantation of BonoFill to the maxillary or mandible defect/void is safe under the following conditions: No chronic bone infection (Osteomyelitis); no significant changes in complete blood count (CBC) and in general health.
Secondary endpoint: The implantation of BonoFill to the maxillary or mandible void is efficient under the following conditions: Following BonoFill implantation, the bone regeneration in the operated site was significantly accelerated. Also, the bone defects/voids were filled with a significant amount of bone tissue.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Kfar Saba, Israel
- Dr. Ephraim Zur Dental Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
The inclusion criteria defining the eligible subjects are divided to two groups according clinical indications:
Sinus augmentation
- Subjects in general good health in the opinion of the investigator as determined by medical history, vital signs physical examination and safety lab tests
- Subjects that have a rehabilitation dentist and rehabilitation program
- Up to dated panoramic X-Ray.
- Subjects who provided written informed consent to participate in the study, able to understand study procedure and agree for follow up procedures
- Healthy conditions of Maxillary Sinuses and Oral Mucosa.
- Sub-antral bone at least 4 mm as measured on CBCT/CT.
- Have a good oral hygiene condition as per investigator discretion.
Bone grafting after removal of cysts from jaws
- Healthy subject.
- Subjects that have a rehabilitation dental treatment.
- Limited to cysts diagnosed as: radicular cysts, residual cysts, congenital cysts, developmental and acquired cysts.
- Subjects referred to oral & maxillofacial Dpt for removal of cysts after diagnosis of the cyst type.
- Healthy bone determined by X-ray.
- Have a good oral hygiene condition.
- Subject that does not participate in other clinical study.
- Subject able to read and understand and sign the informed consent
Exclusion Criteria:
- Subjects with recorded medical history diseases as: diabetes mellitus, heart diseases, renal failure, osteoporosis.
- Subject treated with systemic steroid treatment
- Subjects with known autoimmune diseases, such as: Addison's disease Celiac disease - sprue (gluten-sensitive enteropathy), Dermatomyositis Graves disease, Hashimoto's thyroiditis, Multiple sclerosis, Myasthenia gravis Pernicious anemia, Reactive arthritis, Rheumatoid arthritis, Sjogren syndrome Systemic lupus erythematosus, Type I diabetes.
- Subjects that have Vitiligo and/or known scar healing problems (keloid formation).
- Subjects treated with anticoagulation medication (such as Coumadin, Plavix and other similar medications)
- Subjects treated with Oral Bisphosphonate drugs (such as Fosalan and other similar medications)
- Subjects with a history of Chemotherapy or Radiotherapy treatment
- In case of sinus augmentation - Unhealthy conditions of Maxillary Sinuses.
- Subjects with current active infection or illness
- Subjects participating in another clinical trial 30 days prior to and during the study period
- Pregnant or lactating woman. Pregnancy will be verified by urine test during screening
- Known history of any significant medical disorder, which in the investigator's judgment contraindicates the subject's participation
- Subjects with any known allergy for anesthesia
- Positive serology for either HIV, hepatitis B or hepatitis C
- Abnormal clinically significant as per investigator's judgment laboratory test and exams findings
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: single arm, Liposuction, BonoFill Transplantation
|
Liposuction - will be performed on Visit 2, BonoFill will be based on subject's autologous Human Adipose Tissue Derived Cells (HATDCs). BonoFill Transplantation will be performed on Visit 6. BonoFill will be administrated to the subject in a single session at one tested cell dose.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BonoFill is safe
Time Frame: approximately 6 month follow up after implantation
|
The implantation of BonoFill to the maxillary or mandible defect/void is safe under the following conditions: No chronic bone infection (Osteomyelitis); no significant changes in complete blood count (CBC) and in general health.
|
approximately 6 month follow up after implantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BonoFill is efficient
Time Frame: approximately 6 month follow up after implantation
|
The implantation of BonoFill to the maxillary or mandible void is efficient under the following conditions: Following BonoFill implantation, the bone regeneration in the operated site was significantly accelerated.
Also, the bone defects/voids were filled with a significant amount of bone tissue.
|
approximately 6 month follow up after implantation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yaniv Stolero, Dr, MY
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CP-BNS-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Void in the Maxillofacial Area
-
Merz North America, Inc.CompletedVolume Loss in the Infraorbital Hollow AreaUnited States, Puerto Rico
-
Loma Linda UniversityAmerican Regent, Inc.CompletedInadequate Bone Height in Maxillary Posterior AreaUnited States
-
Merz North America, Inc.CompletedCorrection of Volume Loss in the Infraorbital Hollow AreaUnited States
-
Clinical Research Office of the Endourological...CompletedComparison of Images of the Same Area in the Bladder in Four Different SPIES Modalities on a Tablet Computer
-
All India Institute of Medical Sciences, New DelhiIndian Council of Medical ResearchUnknownHoming of Stem Cells in the Infarct Area.India
-
Karolinska InstitutetCompletedPost Menopausal Dryness in the Intimate Area of WomenSweden
-
Dow University of Health SciencesRecruitingTo Assess the Bone Healing in Fracture Mandible DefectsPakistan
-
Hospices Civils de LyonRecruitingSignificant Bone Defect in the OrbitFrance
-
Henry Ford Health SystemCompletedTo Assess the Changes in Markers of Bone Turnover Over a Six Month Period After Epidural Steroid Inject | To Assess the Changes in Bone Mineral DensityUnited States
-
Cairo UniversityUnknownCompromised Vertical Bone Height in the Maxillary Posterior Region
Clinical Trials on Single Arm - Liposuction procedure and BonoFill transplantation will be done for all subjects on study
-
VA Office of Research and DevelopmentVA Boston Healthcare SystemRecruitingMild Cognitive Impairment | Mild Traumatic Brain Injury | Moderate Traumatic Brain InjuryUnited States
-
Tehran University of Medical SciencesUnknownMetabolic Syndrome XIran, Islamic Republic of
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Inonu UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterCompletedRectal CancerUnited States
-
Zagazig UniversityCompletedAtypical Endometrial HyperplasiaEgypt
-
PfizerCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingConfirmed Diagnosis of ß-thalassemia MajorUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Diagram B.V.Completed